Medicines to help lungs recover after TB
Treatments studied
Part of Infections clinical trials.
This study tests whether two medicines, metformin and N-acetylcysteine, can help your lungs heal better after tuberculosis (TB). You will receive one of these study drugs along with your regular TB treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with TB in your lungs
- You are able to take the standard 6-month TB treatment
- Your lung function is reduced (FEV1 at or below 65% of expected)
- Your weight is between 30 and 90 kg
- You do not have other serious lung diseases like COPD or asthma
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests different treatment plans for people with tuberculosis (TB) that can be cured with standard medicines. It aims to find the best treatment for each person based on their risk score, which may lead to shorter or more effective treatment.
This study tests whether adding the cholesterol drug atorvastatin to standard TB treatment helps people recover faster. It is for people with newly diagnosed, drug-sensitive tuberculosis who have not yet started treatment.
This trial tests whether adding omega-3 (fish oil) to standard TB treatment helps clear the infection faster and reduces inflammation. You may be eligible if you have confirmed lung TB and meet a few health criteria.
This trial tests a new “triple-dose” set of medicines to treat people whose tuberculosis (TB) has come back in the lungs. If you qualify, the goal is to improve cure rates and reduce the chance of TB returning again.
This trial tests if taking N-acetylcysteine (NAC) alongside standard TB treatment can help prevent long-term lung problems after tuberculosis. It is for people with moderate to severe TB who already have some reduced lung function.
This trial studies whether atorvastatin (a cholesterol medicine) can reduce ongoing inflammation after you finish standard tuberculosis (TB) treatment. If it works, it may improve how your body recovers after TB, especially by lowering inflammation-related signals.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.